Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy

Cisplatin/pemetrexed chemotherapy has been established as a standard treatment in lung adenocarcinoma. However, the response to the cisplatin/pemetrexed combination varies considerably among patients due to individual variations. Thus, novel biomarkers are required to aid the prediction of the respo...

Descripción completa

Detalles Bibliográficos
Autores principales: MOU, WENJUN, XUE, HUI, TONG, HONGLI, SUN, SHENGJIE, ZHANG, ZHUHONG, ZHANG, CHUNYAN, SUN, QIYU, DONG, JING, WEN, XINYU, YAN, GUANGTAO, TIAN, YAPING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049753/
https://www.ncbi.nlm.nih.gov/pubmed/24932291
http://dx.doi.org/10.3892/ol.2014.1988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049753/
https://www.ncbi.nlm.nih.gov/pubmed/24932291
http://dx.doi.org/10.3892/ol.2014.1988

Ejemplares similares